News Release
Darmstadt, September 6, 2010 – Merck KGaA announced today that it will be introducing Parteck® Mg DC, the latest addition to its Parteck® Functional Particle Engineering concept, at the CPhI Worldwide in Paris from October 5 -7, 2010. Like all Parteck® products, this special magnesium salt is ideally suited as a specialty excipient for solid dosage forms such as tablets, capsules and powders. The special feature: Parteck® Mg DC is directly compressible without the need for any binders. This means it is much simpler to manufactureend products since various process steps can be dispensed with. Far fewer ingredients require declaration compared with the previous Mg-containing tablets.
Large surface – far-reaching effect
Parteck® Mg DC is the first pure magnesium hydroxide carbonate on the market that makes it possible to compress high-quality tablets directly without the need for binders. A unique particle morphology is one of its outstanding properties. Thanks to its exceptional particle structure and large BET surface, it is readily compressible, and a brilliant adsorbent.
Formulators can produce small, hard tablets with very high Mg concentrations — a feature that offers tremendous advantages in many conventional formulations. For example, the magnesium concentration of various antacids or mineral and food supplements often exceeds 40%. The use of Parteck® Mg DC also eliminates the need for various process steps during production as direct compressibility means no extra granulation is required. Parteck® Mg DC – an all-round success in terms of both functionality and economic efficiency!
Parteck® Mg DC is the latest achievement made possible by the Merck Functional Particle Engineering concept. It meets all the applicable purity requirements in the food and pharmaceutical sectors. Pharmacopoeia declarations are available and the EMPROVE® dossier is expected to be ready as of 2011.
